Back to Authors

Waltz, Michael

https://orcid.org/0009-0008-8859-0362

Mayo Clinic

University of Utah

Citations 27

Evaluating the Use and Efficacy of Avonex and Plegridy in Pediatric Patients (P11-6.005)
Barney, Bradley J. , Peterson, Skyler, Waltz, Michael , Wright, Melissa W., Rose, John , Abrams, Aaron , Wheeler, Yolanda , Tillema, Jan‐Mendelt , Gorman, Mark , Lotze, Timothy , Mar, Soe , Schreiner, Teri , Vignos, Megan , Planton, Jonathan, Casper, T. Charles , Wright, Melissa, Rensel, Mary R. , Waubant, Emmanuelle L. , Rodriguez, Moses , Krupp, Lauren , Benson, Leslie , Shukla, Nikita , Chitnis, Tanuja , Schreiner, Teri

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206450 Get It

Patterns of Use and Safety of Newer Disease-modifying therapies in Pediatric Multiple Sclerosis in the US (S51.004)
Aaen, Gregory , Gorman, Mark , Harris, Yolanda, Lotze, Timothy , Mar, Soe , Moodley, Manikum , Rose, John , Schreiner, Teri , Waltz, Michael , Casper, T. Charles , Krysko, Kristen M. , Graves, Jennifer , Rensel, Mary R. , Benson, Leslie , Chitnis, Tanuja , Goyal, Manu S. , Krupp, Lauren , Rodriguez, Moses , Schreiner, Teri , Weinstock‐Guttman, Bianca , Waubant, Emmanuelle L.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s51.004 Get It

Distribution and predictors of disease severity in pediatric multiple sclerosisInvestigate the distribution of disease severity in pediatric-onset multiple sclerosis (MS). (S49.008)
Waltz, Michael , Casper, Charles, Aaen, Gregory , Belman, Anita , Candee, Meghan , Gorman, Mark , Harris, Yolanda, Kahn, Ilana , Lotze, Timothy , Mar, Soe , Moodley, Manikum , Ness, Jayne , Rose, John , Schreiner, Teri , Tillema, Jan‐Mendelt , Santoro, Jonathan D. , Chitnis, Tanuja , Benson, Leslie , Goyal, Manu S. , Graves, Jennifer , Greenberg, Benjamin , Krupp, Lauren , Rensel, Mary R. , Rodriguez, Moses , Rubin, Jennifer , Schreiner, Teri , Waldman, Amy , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s49.008 Get It

Dietary Factors and Risk of Pediatric Multiple Sclerosis (S29.006)
Pakpoor, Julia, Seminatore, Brandon, Schreiner, Teri , Lotze, Timothy , Belman, Anita , Aaen, Gregory , Tillema, Jan‐Mendelt , Hart, Janace, Ness, Jayne , Harris, Yvonne , Candee, Meghan , Gorman, Mark , Rodríguez, M. D. González, Mar, Soe , Kahn, Ilana , Rose, John , Roalstad, Shelly, Waltz, Michael , Casper, Charlie, Graves, Jennifer , Schreiner, Teri , Waldman, Amy , Greenberg, Benjamin , Weinstock‐Guttman, Bianca , Rubin, Jennifer , Krupp, Lauren , Benson, Leslie , Chitnis, Tanuja , Waubant, Emmanuelle L.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.s29.006 Get It

Allergies in Pediatric Multiple Sclerosis: A Case-Control Study (P1.380)
Neiderer, Theresa, Waltz, Michael , Casper, Charlie, Kavak, Katelyn , Aaen, Gregory , Belman, Anita , Candee, Meghan , Gorman, Mark , Harris, Yolanda, Hart, Janace, Kahn, Ilana , Lotze, Timothy , Mar, Soe , Ness, Jayne , Olsen, Cody S., Roalstad, Shelly, Rose, John , Schreiner, Teri , Simmons, Timothy , Tillema, Jan‐Mendelt , Benson, Leslie , Chitnis, Tanuja , Graves, Jennifer , Greenberg, Benjamin , Krupp, Lauren , Rodriguez, Moses , Rubin, Jennifer , Schreiner, Teri , Vanderver, Adeline , Waldman, Amy , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p1.380 Get It

Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)
Aaen, Gregory , Belman, Anita , Gorman, Mark , Harris, Yolanda, Lotze, Timothy , Mar, Soe , Moodley, Manikum , Ness, Jayne , Rodriguez, M Herrera, Rose, John , Schreiner, Teri , Tillema, Jan‐Mendelt , Waltz, Michael , Casper, T. Charles , Krysko, Kristen M. , Graves, Jennifer , Rensel, Mary R. , Weinstock‐Guttman, Bianca , Rutatangwa, Alice , Benson, Leslie , Chitnis, Tanuja , Goyal, Manu S. , Krupp, Lauren , Schreiner, Teri , Waubant, Emmanuelle L.

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.625 Get It

Menarche and Relapses in Girls with Pediatric Multiple Sclerosis (1270)
Waltz, Michael , Aaen, Gregory , Harris, Yolanda, Lotze, Timothy , Mar, Soe , Ness, Jayne , Rose, John , Schreiner, Teri , Casper, T. Charles , Krysko, Kristen M. , Chitnis, Tanuja , Weinstock‐Guttman, Bianca , Benson, Leslie , Krupp, Lauren , Rensel, Mary R. , Rodriguez, Moses , Rutatangwa, Alice , Schreiner, Teri , Waubant, Emmanuelle L. , Graves, Jennifer

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1270 Get It

Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US (P14-3.008)
Abrams, Aaron , Waltz, Michael , Casper, T. Charles , Aaen, Gregory , Francisco, Carla , Gorman, Mark , Graves, Jennifer, Lotze, Timothy , Mar, Soe , Rose, John , Schreiner, Teri , Tillema, Jan‐Mendelt , Wheeler, Yolanda , Benson, Leslie , Charvet, Leigh , Chitnis, Tanuja , Goyal, Manu S. , Krupp, Lauren , Rensel, Mary R. , Rodriguez, Moses , Rutatangwa, Alice , Schreiner, Teri , Shukla, Nikita , Weinstock‐Guttman, Bianca , Waubant, Emmanuelle L. , Krysko, Kristen M.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203650 Get It

Longitudinal Cognitive Screening Findings in Pediatric MS vs. Pediatric Controls and Adult MS in a Multi-center Cohort (S31.008)
O’Neill, Kimberly, Waltz, Michael , Casper, T. Charles , George, Allan , Gorman, Mark , Mar, Soe , Ness, Jayne , Schreiner, Teri , Wheeler, Yolanda , Aaen, Gregory , Abrams, Aaron , Lotze, Timothy , Rose, John , Tillema, Jan‐Mendelt , O'Neill, Kimberly , Charvet, Leigh , Benson, Leslie, Goyal, Manu S. , Schreiner, Teri , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca , Chitnis, Tanuja , Rensel, Mary R. , Rodriguez, Moses , Shukla, Nikita , Krupp, Lauren

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201998 Get It

Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2
Schreiner, Teri , Wilson-Murphy, Molly , Mendelt-Tillema, Jan, Waltz, Michael , Codden, Rachel , Gorman, Mark , Krupp, Lauren , Lotze, Tim, Mar, Soe , Ness, Jayne , Roalstad, Shelly, Rose, John , Shukla, Nikita , Wheeler, Yolanda , Casper, T. Charles , Krupp, Lauren , Rensel, Mary R. , Chitnis, Tanuja , Schreiner, Teri , Shukla, Nikita Malani , Benson, Leslie, Goyal, Manu S. , Rodriguez, Moses , Waubant, Emmanuelle L.

Multiple Sclerosis Journal | March 24, 2023 | Volume: 29 | Issue: 4-5 | Pages: 576-584

10.1177/13524585231151948 Get It

Background: Pediatric patients with multiple sclerosis (POMS) and related disorders, clinically isolated syndrome (CIS), myelin oligodendrocyte glycoprotein antibody disorder (MOGAD), and neuromyelitis optica spectrum disorder (NMOSD), are commonly treated with immunosuppressants. Understanding the impact of SARS-CoV-2 infection in patients may inform treatment decisions. Objective: Characterize SARS-CoV-2 infection prevalence and severity among a cohort of patients with POMS and related disorders, as well as the impact of disease-modifying therapies (DMTs). Methods: POMS and related disorders patients enrolled in a large, prospective registry were screened for COVID-19 during standard-of-care neurology visits. If confirmed positive of having infection, further analysis was undertaken. Results: Six hundred and sixty-nine patients were surveyed between March 2020 and August 2021. There were 73 confirmed COVID-19 infections. Eight of nine hospitalized patients (89%), and all patients admitted to the ICU were treated with B cell depleting therapy. The unadjusted odds ratio of hospitalization among those who tested positive of having had COVID-19 was 15.27 among those on B-cell-depleting therapy ( p = 0.016). Conclusions: B-cell-depleting treatment was associated with a higher risk of COVID-19, higher rates of hospitalization, and ICU admission, suggesting this therapy carries a higher risk of severe infection in POMS and related disorders.